| Notes to the financial statements | Note 3 |
|
| Company |
|
|
|
Group |
|
| 2017 |
|
2016 |
|
|
(R’million) |
2017 |
|
2016
Restated |
*# |
| |
|
|
|
3 |
Operating income/(loss) before
impairments and abnormal items |
|
|
|
|
| |
|
|
|
3.1 |
Operating income/(loss) has been determined after charging/(crediting): |
|
|
|
|
| |
|
|
|
|
External auditors’ remuneration |
29,9 |
|
33,1 |
|
| |
|
|
|
|
Audit fees |
25,0 |
|
29,1 |
|
| |
|
|
|
|
Other fees and expenses |
4,9 |
|
4,0 |
|
| |
|
|
|
|
Internal auditors’ remuneration |
7,1 |
|
13,5 |
|
| |
|
|
|
|
Depreciation |
552,5 |
|
524,5 |
|
| |
|
|
|
|
Buildings |
57,7 |
|
51,9 |
|
| |
|
|
|
|
Plant, equipment and vehicles |
489,7 |
|
470,6 |
|
| |
|
|
|
|
Capitalised leased assets |
5,1 |
|
2,0 |
|
| |
|
|
|
|
Amortisation |
11,4 |
|
11,6 |
|
| |
|
|
|
|
Trademarks, licence agreements and other intangibles |
10,8 |
|
11,1 |
|
| |
|
|
|
|
Customer lists |
0,6 |
|
0,5 |
|
| |
|
|
|
|
Operating lease charges |
372,7 |
|
194,7 |
|
| |
|
|
|
|
Land and buildings |
158,8 |
|
71,2 |
|
| |
|
|
|
|
Plant, equipment and vehicles |
213,9 |
|
123,5 |
|
| |
|
|
|
|
Loss on disposal of plant, equipment and vehicles |
5,0 |
|
1,2 |
|
| |
|
|
|
|
Research, development and related expenditure |
16,4 |
|
15,6 |
|
| |
|
|
|
|
IFRS 2 charges |
110,3 |
|
88,9 |
|
| |
|
|
|
|
Cash settled |
12,6 |
|
18,0 |
|
| |
|
|
|
|
Equity settled, including BEE-related IFRS 2 charges |
97,7 |
|
70,9 |
|
| |
|
|
|
|
Staff costs |
3 319,2 |
|
3 215,7 |
|
| |
|
|
|
|
Employer’s contribution to retirement funding |
239,4 |
|
238,9 |
|
| |
|
|
|
|
Employer’s contribution to medical aid |
85,6 |
|
86,9 |
|
| 0,4 |
|
5,7 |
|
|
Foreign exchange (profit)/loss |
(17,7) |
|
23,6 |
|
| |
|
|
|
|
Rental income and fee income |
(11,4) |
|
(13,3) |
|
| |
|
|
|
3.2 |
Directors’ emoluments |
|
|
|
|
| |
|
|
|
|
Executive directors |
|
|
|
|
| |
|
|
|
|
– Salaries and bonuses |
17,8 |
|
18,8 |
|
| |
|
|
|
|
– Retirement, medical and other benefits |
14,5 |
|
49,3 |
|
| |
|
|
|
|
Non-executive directors |
|
|
|
|
| 8,2 |
|
7,8 |
|
|
– Fees |
8,2 |
|
7,8 |
|
| 8,2 |
|
7,8 |
|
|
Total directors’ emoluments |
40,5 |
|
75,9 |
|
| |
|
|
|
|
Less: Paid by subsidiaries |
(32,3) |
|
(68,1) |
|
| 8,2 |
|
7,8 |
|
|
Emoluments paid by company |
8,2 |
|
7,8 |
|
| |
|
|
|
|
For more details refer to Annexure C |
|
|
|
|
| * |
Restated for the early adoption of IFRS 15 Revenue from Contracts with Customers. Refer to note 6. |
| # |
Restated as required by IFRS 5 in relation to the treatment of East Africa Tiger Brands Industries Plc. (EATBI) and Haco Tiger Brands (E.A.) Limited (Haco) as discontinued operations. Refer to note 34. |
| Notes to the financial statements | Note 3 |
|
|